Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PMCBthis companyPharmaCyte Biotech, Inc.	$0.37	-0.26×	0.15×	0×	2.55×	614.5%	0.0%	0.0%	0.0%	-58.3%	-14.9%	-101.8%	0×	3.51×	0×	45.28×	4.9%	2	-3.39	2	B-
IBOImpact BioMedical Inc.	$4.03	-1.33×	1.26×	497.66×	-1.27×	-100.4%	-1225.0%	-13343.8%	-36993.8%	-93.9%	-21.6%	-11.9%	0×	0×	-5.38×	0.35×	0.0%	4	2.31	2	C+
KTTAPasithea Therapeutics Corp.	$0.61	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
QNRXQuoin Pharmaceuticals, Ltd.	$3.86	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
TCRTAlaunos Therapeutics, Inc.	$1.76	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
VIVSVivoSim Labs, Inc.	$0.15	-0.27×	-3.37×	28.25×	0.07×	989.3%	100.0%	-8567.9%	-10567.2%	1259.6%	-222.3%	-292.5%	-0.41×	0.34×	-935.33×	2.38×	0.0%	1	-139.92	2	B-
Peer median	—	-1.33×	1.26×	28.25×	0.07×	989.3%	0.0%	-8567.9%	-10567.2%	-93.9%	-109.7%	-62.6%	0×	0.34×	0×	2.45×	0.0%	1	-13.64	2	—